Contact this trialFirst, we need to learn more about you.
[89Zr]Panitumumab Imaging for Head and Neck Cancer
Recruiting1 awardPhase < 1
Birmingham, Alabama
This trial tests a new imaging method using a special radioactive substance to better locate and measure head and neck tumors in patients. It aims to provide clearer images than the current standard method. The study involves injecting a small amount of a drug to help the radioactive substance attach to the tumor cells, making them more visible on scans.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service